Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
1962 4
1963 15
1964 26
1965 9
1967 5
1969 3
1971 2
1972 1
1974 1
1975 4
1976 1
1977 5
1978 5
1979 8
1981 6
1982 8
1983 3
1984 9
1985 12
1986 12
1987 4
1988 8
1989 12
1990 8
1991 7
1992 3
1993 17
1994 15
1995 13
1996 14
1997 12
1998 18
1999 19
2000 23
2001 23
2002 20
2003 31
2004 39
2005 28
2006 28
2007 33
2008 32
2009 37
2010 27
2011 26
2012 39
2013 42
2014 47
2015 67
2016 51
2017 54
2018 52
2019 38
2020 33
2021 46
2022 25
2023 27
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

1,095 results

Results by year

Filters applied: . Clear all
Page 1
Acenocoumarol.
[No authors listed] [No authors listed] 2020 Nov 16. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2020 Nov 16. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000568 Free Books & Documents. Review.
Acenocoumarol is not approved for marketing in the United States by the U.S. ...No changes in coagulation measurements or adverse reactions in breastfed infants have been reported from maternal acenocoumarol use during lactation. There is a consensus that maternal …
Acenocoumarol is not approved for marketing in the United States by the U.S. ...No changes in coagulation measurements or adverse rea …
Biomodification of acenocoumarol by bifidobacteria.
Fragomeno M, Assad S, Mobili P, Peruzzo PJ, Minnaard J, Pérez PF. Fragomeno M, et al. FEMS Microbiol Lett. 2021 Oct 4;368(18):fnab125. doi: 10.1093/femsle/fnab125. FEMS Microbiol Lett. 2021. PMID: 34529059
In this context, these studies are relevant for drugs such as acenocoumarol, whose dosage must be controlled due to, among other factors, food-drug interactions. Acenocoumarol is an oral anticoagulant with a narrow therapeutic range. ...
In this context, these studies are relevant for drugs such as acenocoumarol, whose dosage must be controlled due to, among other fact …
Rosuvastatin-acenocoumarol interaction.
Mondillo S, Ballo P, Galderisi M. Mondillo S, et al. Clin Ther. 2005 Jun;27(6):782-4. doi: 10.1016/j.clinthera.2005.06.007. Clin Ther. 2005. PMID: 16117985
CONCLUSIONS: Based on the results of this case, a possible pharmacologic interaction between rosuvastatin and acenocoumarol should be considered. Rosuvastatin might enhance the anticoagulant effect of acenocoumarol, and a rebound effect in cases of simultaneous disc …
CONCLUSIONS: Based on the results of this case, a possible pharmacologic interaction between rosuvastatin and acenocoumarol should be …
Acenocoumarol: A Review of Anticoagulant Efficacy and Safety.
Trailokya A, Hiremath JS, Sawhney J, Mishra YK, Kanhere V, Srinivasa R, Tiwaskar M. Trailokya A, et al. J Assoc Physicians India. 2016 Feb;64(2):88-93. J Assoc Physicians India. 2016. PMID: 27730796 Review.
Acenocoumarol is effective and safe in all age groups. It offers an advantage over warfarin in terms of better stability of anti-coagulant effect. Due to its economic advantage acenocoumarol may be suitable oral anticoagulant for long term use in countries like Indi …
Acenocoumarol is effective and safe in all age groups. It offers an advantage over warfarin in terms of better stability of anti-coag …
ACENOCOUMAROL.
[No authors listed] [No authors listed] J Am Med Assoc. 1958 May 3;167(1):62. J Am Med Assoc. 1958. PMID: 13538672 No abstract available.
A Brief Review on Determination of Acenocoumarol in Biological and Pharmaceutical Specimens: Analytical Methodologies.
Chaudhari SR, Mhaske PD, Shirkhedkar AA. Chaudhari SR, et al. Crit Rev Anal Chem. 2022;52(3):627-636. doi: 10.1080/10408347.2020.1815169. Epub 2020 Sep 8. Crit Rev Anal Chem. 2022. PMID: 32897755 Review.
Acenocoumarol is prescribed in the form of racemic mixture and S- form is a more influential isomer. Acenocoumarol starts quickly with action and absorption, and the effect lasts for 15-20 h. ...
Acenocoumarol is prescribed in the form of racemic mixture and S- form is a more influential isomer. Acenocoumarol starts quic …
Warfarin pharmacogenomics: current best evidence.
Kimmel SE. Kimmel SE. J Thromb Haemost. 2015 Jun;13 Suppl 1:S266-71. doi: 10.1111/jth.12978. J Thromb Haemost. 2015. PMID: 26149035 Free article. Review.
The utility of using genetic information to guide warfarin dosing has remained unclear based on prior observational studies and small clinical trials. Two larger trials of warfarin and one of the acenocoumarol and phenprocoumon have recently been published. The COAG trial …
The utility of using genetic information to guide warfarin dosing has remained unclear based on prior observational studies and small clinic …
Acenocoumarol's pharmacokinetic: linear or not?
Kumar P, Kapoor P, Meenu C. Kumar P, et al. EXCLI J. 2019 Aug 27;18:679-682. doi: 10.17179/excli2019-1714. eCollection 2019. EXCLI J. 2019. PMID: 31611751 Free PMC article. No abstract available.
Acenocoumarol-induced Henoch-Schonlein purpura.
Borrás-Blasco J, Girona E, Navarro-Ruiz A, Matarredona J, Giménez ME, Gutiérrez A, Enriquez R, Martinez A. Borrás-Blasco J, et al. Ann Pharmacother. 2004 Feb;38(2):261-4. doi: 10.1345/aph.1D270. Epub 2003 Dec 23. Ann Pharmacother. 2004. PMID: 14742763
OBJECTIVE: To report a probable case of Henoch-Schonlein purpura associated with acenocoumarol therapy. CASE SUMMARY: A 76-year-old white woman was prescribed acenocoumarol for chronic atrial fibrillation. ...DISCUSSION: The most likely cause of the Henoch-Schonlein …
OBJECTIVE: To report a probable case of Henoch-Schonlein purpura associated with acenocoumarol therapy. CASE SUMMARY: A 76-year-old w …
1,095 results